Antonio Laghezza

2.3k total citations
89 papers, 1.9k citations indexed

About

Antonio Laghezza is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Antonio Laghezza has authored 89 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Molecular Biology, 21 papers in Oncology and 21 papers in Cancer Research. Recurrent topics in Antonio Laghezza's work include Peroxisome Proliferator-Activated Receptors (39 papers), Metabolism, Diabetes, and Cancer (18 papers) and Protease and Inhibitor Mechanisms (17 papers). Antonio Laghezza is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (39 papers), Metabolism, Diabetes, and Cancer (18 papers) and Protease and Inhibitor Mechanisms (17 papers). Antonio Laghezza collaborates with scholars based in Italy, United States and Spain. Antonio Laghezza's co-authors include Fulvio Loiodice, Paolo Tortorella, Antonio Lavecchia, Luca Piemontese, G. Pochetti, Giuseppe Fracchiolla, Roberta Montanari, Davide Capelli, Maurizio Crestani and Ettore Novellino and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Antonio Laghezza

87 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonio Laghezza Italy 28 1.2k 393 327 290 242 89 1.9k
Fulvio Loiodice Italy 31 1.7k 1.4× 586 1.5× 396 1.2× 317 1.1× 245 1.0× 117 2.7k
Paolo Tortorella Italy 31 1.4k 1.2× 723 1.8× 317 1.0× 497 1.7× 433 1.8× 109 2.6k
Simona Saponara Italy 28 1.1k 0.9× 290 0.7× 215 0.7× 348 1.2× 230 1.0× 79 2.3k
Toshimasa Itoh Japan 22 791 0.6× 250 0.6× 178 0.5× 122 0.4× 126 0.5× 68 1.5k
Rosa Amoroso Italy 28 1.1k 0.9× 941 2.4× 166 0.5× 149 0.5× 175 0.7× 124 2.3k
Parimal Misra India 27 1.1k 0.9× 679 1.7× 194 0.6× 136 0.5× 152 0.6× 63 2.0k
Ying Leng China 29 1.3k 1.1× 314 0.8× 295 0.9× 335 1.2× 127 0.5× 103 2.5k
Eun‐Ryeong Hahm United States 35 1.8k 1.5× 288 0.7× 276 0.8× 409 1.4× 385 1.6× 84 3.2k
Alessandra Ammazzalorso Italy 24 837 0.7× 634 1.6× 144 0.4× 127 0.4× 143 0.6× 90 1.6k
Abid Hamid India 30 1.3k 1.0× 391 1.0× 372 1.1× 200 0.7× 248 1.0× 89 2.6k

Countries citing papers authored by Antonio Laghezza

Since Specialization
Citations

This map shows the geographic impact of Antonio Laghezza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Laghezza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Laghezza more than expected).

Fields of papers citing papers by Antonio Laghezza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Laghezza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Laghezza. The network helps show where Antonio Laghezza may publish in the future.

Co-authorship network of co-authors of Antonio Laghezza

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Laghezza. A scholar is included among the top collaborators of Antonio Laghezza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Laghezza. Antonio Laghezza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laghezza, Antonio, Federica Gilardi, Aurélien Thomas, et al.. (2025). A new potent and selective peroxisome proliferator-activated receptor alpha partial agonist displays anti-steatotic effects In vitro and behaves as a safe hypolipidemic and hypoglycemic agent in a diabetic mouse model. European Journal of Medicinal Chemistry. 289. 117494–117494. 1 indexed citations
2.
Barbarossa, Alexia, Antonio Laghezza, Alessia Carocci, et al.. (2025). Deep Eutectic Solvents (DESs) as Alternative Sustainable Media for the Extraction and Characterization of Bioactive Compounds from Winemaking Industry Wastes. Molecules. 30(8). 1855–1855. 3 indexed citations
3.
Laghezza, Antonio, Carmen Cerchia, Inmaculada Fernández, et al.. (2024). Synthesis and in vitro cytotoxicity of benzoxazole‐based PPARα/γ antagonists in colorectal cancer cell lines. Archiv der Pharmazie. 357(9). e2400086–e2400086. 4 indexed citations
4.
Carrieri, Antonio, Sı́lvia Chaves, Leonardo Brunetti, et al.. (2024). Rivastigmine structure-based hybrids as potential multi-target anti-Alzheimer’s drug candidates. Bioorganic Chemistry. 153. 107895–107895.
5.
Capelli, Davide, Matteo Mori, Antonio Laghezza, et al.. (2023). Biological Screening and Crystallographic Studies of Hydroxy γ-Lactone Derivatives to Investigate PPARγ Phosphorylation Inhibition. Biomolecules. 13(4). 694–694. 3 indexed citations
6.
Laghezza, Antonio, Carmen Cerchia, Erica Pranzini, et al.. (2023). A New Antidiabetic Agent Showing Short- and Long-Term Effects Due to Peroxisome Proliferator-Activated Receptor Alpha/Gamma Dual Agonism and Mitochondrial Pyruvate Carrier Inhibition. Journal of Medicinal Chemistry. 66(5). 3566–3587. 5 indexed citations
7.
Abate, Carmen, Domenico Alberga, Antonio Laghezza, et al.. (2023). AMALPHI: A Machine Learning Platform for Predicting Drug-Induced PhospholIpidosis. Molecular Pharmaceutics. 21(2). 864–872. 2 indexed citations
8.
Cerchia, Carmen, Antonio Laghezza, Luca Piemontese, et al.. (2022). A chemoinformatics search for peroxisome proliferator-activated receptors ligands revealed a new pan-agonist able to reduce lipid accumulation and improve insulin sensitivity. European Journal of Medicinal Chemistry. 235. 114240–114240. 7 indexed citations
9.
Carocci, Alessia, Alexia Barbarossa, Antonio Carrieri, et al.. (2022). Novel Phenothiazine/Donepezil-like Hybrids Endowed with Antioxidant Activity for a Multi-Target Approach to the Therapy of Alzheimer’s Disease. Antioxidants. 11(9). 1631–1631. 18 indexed citations
10.
Intranuovo, Francesca, Leonardo Brunetti, Pietro Delre, et al.. (2022). Development of N-(1-Adamantyl)benzamides as Novel Anti-Inflammatory Multitarget Agents Acting as Dual Modulators of the Cannabinoid CB2 Receptor and Fatty Acid Amide Hydrolase. Journal of Medicinal Chemistry. 66(1). 235–250. 5 indexed citations
11.
Tilekar, Kalpana, Neha Upadhyay, Antonio Laghezza, et al.. (2021). Thiazolidinedione “Magic Bullets” Simultaneously Targeting PPARγ and HDACs: Design, Synthesis, and Investigations of their In Vitro and In Vivo Antitumor Effects. Journal of Medicinal Chemistry. 64(10). 6949–6971. 29 indexed citations
12.
Ammazzalorso, Alessandra, Isabella Bruno, Rosalba Florio, et al.. (2020). Sulfonimide and Amide Derivatives as Novel PPARα Antagonists: Synthesis, Antiproliferative Activity, and Docking Studies. ACS Medicinal Chemistry Letters. 11(5). 624–632. 16 indexed citations
13.
Brunetti, Leonardo, et al.. (2020). A Review of Recent Patents (2016-2019) on Plant Food Supplements with Potential Application in the Treatment of Neurodegenerative and Metabolic Disorders. Recent Patents on Food Nutrition & Agriculture. 11(2). 145–153. 3 indexed citations
14.
Brunetti, Leonardo, et al.. (2020). Natural Compounds for the Prevention and Treatment of Cardiovascular and Neurodegenerative Diseases. Foods. 10(1). 29–29. 39 indexed citations
15.
Agamennone, Mariangela, Antonio Laghezza, Paolo Tortorella, et al.. (2020). Discovery of 7-aminophenanthridin-6-one as a new scaffold for matrix metalloproteinase inhibitors with multitarget neuroprotective activity. European Journal of Medicinal Chemistry. 210. 113061–113061. 6 indexed citations
16.
Brunetti, Leonardo, Fulvio Loiodice, Luca Piemontese, Paolo Tortorella, & Antonio Laghezza. (2019). New Approaches to Cancer Therapy: Combining Fatty Acid Amide Hydrolase (FAAH) Inhibition with Peroxisome Proliferator-Activated Receptors (PPARs) Activation. Journal of Medicinal Chemistry. 62(24). 10995–11003. 25 indexed citations
17.
Laghezza, Antonio, Luca Piemontese, Paolo Tortorella, & Fulvio Loiodice. (2019). An update about the crucial role of stereochemistry on the effects of Peroxisome Proliferator-Activated Receptor ligands. European Journal of Medicinal Chemistry. 176. 326–342. 5 indexed citations
18.
Laghezza, Antonio, Luca Piemontese, Carmen Cerchia, et al.. (2018). Identification of the First PPARα/γ Dual Agonist Able To Bind to Canonical and Alternative Sites of PPARγ and To Inhibit Its Cdk5-Mediated Phosphorylation. Journal of Medicinal Chemistry. 61(18). 8282–8298. 33 indexed citations
19.
Piemontese, Luca, Marco Catto, Antonio Laghezza, et al.. (2018). Natural Scaffolds with Multi-Target Activity for the Potential Treatment of Alzheimer’s Disease. Molecules. 23(9). 2182–2182. 32 indexed citations
20.
Tauro, Marilena, Gemma Shay, Antonio Laghezza, et al.. (2017). Bone-Seeking Matrix Metalloproteinase-2 Inhibitors Prevent Bone Metastatic Breast Cancer Growth. Molecular Cancer Therapeutics. 16(3). 494–505. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026